Results 151 to 160 of about 726,956 (307)

TOUCH® Patient Reported Outcomes Study: The Impact of Natalizumab on Common Measures of Quality of Life in CD patients [PDF]

open access: bronze, 2012
Sunanda V. Kane   +7 more
openalex   +1 more source

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham   +21 more
wiley   +1 more source

Clinical Outcomes Assessment in Clinical Trials to Assess Treatment of Femoroacetabular Impingement: Use of Patient-reported Outcome Measures [PDF]

open access: green, 2013
Marcie Harris‐Hayes   +5 more
openalex   +1 more source

Decrypting cancer's spatial code: from single cells to tissue niches

open access: yesMolecular Oncology, EarlyView.
Spatial transcriptomics maps gene activity across tissues, offering powerful insights into how cancer cells are organised, switch states and interact with their surroundings. This review outlines emerging computational, artificial intelligence (AI) and geospatial approaches to define cell states, uncover tumour niches and integrate spatial data with ...
Cenk Celik   +4 more
wiley   +1 more source

Surgeon interpretation of patient-reported outcome measures in upper extremity osteoarthritis. [PDF]

open access: yesPLoS One
Looman RS   +7 more
europepmc   +1 more source

Measuring social health in the patient-reported outcomes measurement information system (PROMIS): item bank development and testing

open access: green, 2010
Elizabeth A. Hahn   +9 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy